{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:21:30Z","timestamp":1788448890936,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03600-0","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:53:14Z","timestamp":1788447194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiomics as a spatial context for treatment decision-making in head and neck cancer"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5792-3072","authenticated-orcid":false,"given":"Takeyuki","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"3600_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"3600_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883\u201392.","journal-title":"N Engl J Med"},{"key":"3600_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, de Castro G Jr., et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394:1915\u201328.","journal-title":"Lancet"},{"key":"3600_CR4","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1158\/1078-0432.CCR-18-3944","volume":"25","author":"RL Ferris","year":"2019","unstructured":"Ferris RL, Licitra L, Fayette J, Even C, Blumenschein G Jr., Harrington KJ, et al. Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clin Cancer Res. 2019;25:5221\u201330.","journal-title":"Clin Cancer Res"},{"key":"3600_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.","journal-title":"Nat Commun"},{"key":"3600_CR6","doi-asserted-by":"publisher","first-page":"e011692","DOI":"10.1136\/jitc-2025-011692","volume":"13","author":"P Rai","year":"2025","unstructured":"Rai P, Mahajan A. Radiomics in head and neck squamous cell carcinoma - a leap towards precision oncology. J Immunother Cancer. 2025;13:e011692.","journal-title":"J Immunother Cancer"},{"key":"3600_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"3600_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Vallieres M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology"},{"key":"3600_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.05.053","volume":"102","author":"A Traverso","year":"2018","unstructured":"Traverso A, Wee L, Dekker A, Gillies R. Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys. 2018;102:1143\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3600_CR10","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104\u2013e7.","journal-title":"Cancer Res"},{"key":"3600_CR11","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1097\/JS9.0000000000002715","volume":"111","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Ai S, He Q, Wu K, Yang M, Zheng K, et al. Intratumoral and peritumoral habitat radiomics of MRI predicts pathologic complete response to neoadjuvant chemoimmunotherapy in oral squamous cell carcinoma. Int J Surg. 2025;111:6232\u201344.","journal-title":"Int J Surg"},{"key":"3600_CR12","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/ijms24032214","volume":"24","author":"DC Marcu","year":"2023","unstructured":"Marcu DC, Grava C, Marcu LG. Current role of delta radiomics in head and neck oncology. Int J Mol Sci. 2023;24:2214.","journal-title":"Int J Mol Sci"},{"key":"3600_CR13","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1007\/s00330-023-09843-2","volume":"33","author":"Y Trada","year":"2023","unstructured":"Trada Y, Keall P, Jameson M, Moses D, Lin P, Chlap P, et al. Changes in serial multiparametric MRI and FDG-PET\/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer. Eur Radiol. 2023;33:8788\u201399.","journal-title":"Eur Radiol"},{"key":"3600_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","volume":"38","author":"DM Brizel","year":"1997","unstructured":"Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3600_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ijrobp.2025.10.017","volume":"124","author":"JE Han","year":"2026","unstructured":"Han JE, Diplas BH, Paudyal R, Oh JH, Shridhar AK, Aliotta E, et al. Apparent diffusion coefficient magnetic resonance imaging as a predictive biomarker for hypoxia, treatment de-escalation, and recurrence in human papillomavirus-associated oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2026;124:1015\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3600_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00259-019-04609-9","volume":"47","author":"A Sorensen","year":"2020","unstructured":"Sorensen A, Carles M, Bunea H, Majerus L, Stoykow C, Nicolay NH, et al. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2020;47:1056\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3600_CR17","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.3390\/ijms26146679","volume":"26","author":"M Huang","year":"2025","unstructured":"Huang M, Law HKW, Tam SY. Use of radiomics in characterizing tumor hypoxia. Int J Mol Sci. 2025;26:6679.","journal-title":"Int J Mol Sci"},{"key":"3600_CR18","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.3390\/cancers15225369","volume":"15","author":"TM Nguyen","year":"2023","unstructured":"Nguyen TM, Bertolus C, Giraud P, Burgun A, Saintigny P, Bibault JE, et al. A radiomics approach to identify immunologically active tumor in patients with head and neck squamous cell carcinomas. Cancers (Basel). 2023;15:5369.","journal-title":"Cancers (Basel)"},{"key":"3600_CR19","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1007\/s00330-022-08651-4","volume":"32","author":"YM Zheng","year":"2022","unstructured":"Zheng YM, Yuan MG, Zhou RQ, Hou F, Zhan JF, Liu ND, et al. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur Radiol. 2022;32:5362\u201370.","journal-title":"Eur Radiol"},{"key":"3600_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mp.18028","volume":"52","author":"H Jiang","year":"2025","unstructured":"Jiang H, Zhou L, Zhang Q, Yu T, Yu Z. Radiomics-based prediction of T cell-inflamed gene expression profile and prognosis in head and neck squamous cell carcinoma. Med Phys. 2025;52:e18028.","journal-title":"Med Phys"},{"key":"3600_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/hed.27878","volume":"47","author":"DP Zandberg","year":"2025","unstructured":"Zandberg DP, Zenkin S, Ak M, Mamindla P, Peddagangireddy V, Hsieh R, et al. Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent\/metastatic squamous cell carcinoma of the head and neck patients. Head Neck. 2025;47:129\u201338.","journal-title":"Head Neck"},{"key":"3600_CR22","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301353RR","volume":"38","author":"B Fan","year":"2024","unstructured":"Fan B, Fan B, Sun N, Zou H, Gu X. A radiomics model to predict gammadelta T-cell abundance and overall survival in head and neck squamous cell carcinoma. FASEB J. 2024;38:e23529.","journal-title":"FASEB J"},{"key":"3600_CR23","doi-asserted-by":"publisher","first-page":"e0232639","DOI":"10.1371\/journal.pone.0232639","volume":"15","author":"S Keek","year":"2020","unstructured":"Keek S, Sanduleanu S, Wesseling F, de Roest R, van den Brekel M, van der Heijden M, et al. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. PLoS One. 2020;15:e0232639.","journal-title":"PLoS One"},{"key":"3600_CR24","doi-asserted-by":"publisher","first-page":"e009616","DOI":"10.1136\/jitc-2024-009616","volume":"12","author":"P Lin","year":"2024","unstructured":"Lin P, Xie W, Li Y, Zhang C, Wu H, Wan H, et al. Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma. J Immunother Cancer. 2024;12:e009616.","journal-title":"J Immunother Cancer"},{"key":"3600_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/RCT.0000000000001149","volume":"45","author":"CY Wang","year":"2021","unstructured":"Wang CY, Ginat DT. Preliminary computed tomography radiomics model for predicting pretreatment CD8+ T-cell infiltration status for primary head and neck squamous cell carcinoma. J Comput Assist Tomogr. 2021;45:629\u201336.","journal-title":"J Comput Assist Tomogr"},{"key":"3600_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21159-7","volume":"12","author":"A Rabasco Meneghetti","year":"2022","unstructured":"Rabasco Meneghetti A, Zwanenburg A, Linge A, Lohaus F, Grosser M, Baretton GB, et al. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC. Sci Rep. 2022;12:16755.","journal-title":"Sci Rep"},{"key":"3600_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96821-x","volume":"15","author":"A Corti","year":"2025","unstructured":"Corti A, Lenoci D, Corino VDA, Mattavelli D, Ravanelli M, Poli T, et al. Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma. Sci Rep. 2025;15:12622.","journal-title":"Sci Rep"},{"key":"3600_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00066-019-01478-x","volume":"195","author":"K Zwirner","year":"2019","unstructured":"Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, et al. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol. 2019;195:771\u20139.","journal-title":"Strahlenther Onkol"},{"key":"3600_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104877","volume":"110","author":"E Katsoulakis","year":"2020","unstructured":"Katsoulakis E, Yu Y, Apte AP, Leeman JE, Katabi N, Morris L, et al. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncol. 2020;110:104877.","journal-title":"Oral Oncol"},{"key":"3600_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/RCT.0000000000001213","volume":"45","author":"L Wu","year":"2021","unstructured":"Wu L, Lin P, Zhao Y, Li X, Yang H, He Y. Prediction of genetic alterations in oncogenic signaling pathways in squamous cell carcinoma of the head and neck: radiogenomic analysis based on computed tomography images. J Comput Assist Tomogr. 2021;45:932\u201340.","journal-title":"J Comput Assist Tomogr"},{"key":"3600_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41416-020-0876-9","volume":"123","author":"JH Rasmussen","year":"2020","unstructured":"Rasmussen JH, Olin A, Lelkaitis G, Hansen AE, Andersen FL, Johannesen HH, et al. Does multiparametric imaging with (18)F-FDG-PET\/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma? Br J Cancer. 2020;123:46\u201353.","journal-title":"Br J Cancer"},{"key":"3600_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10371-5","volume":"7","author":"M Vallieres","year":"2017","unstructured":"Vallieres M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts H, et al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep. 2017;7:10117.","journal-title":"Sci Rep"},{"key":"3600_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.radonc.2017.10.023","volume":"125","author":"M Bogowicz","year":"2017","unstructured":"Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, et al. Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol. 2017;125:385\u201391.","journal-title":"Radiother Oncol"},{"key":"3600_CR34","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/hed.27332","volume":"45","author":"C Franzese","year":"2023","unstructured":"Franzese C, Lillo S, Cozzi L, Teriaca MA, Badalamenti M, Di Cristina L, et al. Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer. Head Neck. 2023;45:1184\u201393.","journal-title":"Head Neck"},{"key":"3600_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110702","volume":"204","author":"RM Winter","year":"2025","unstructured":"Winter RM, Boeke S, Leibfarth S, Habrich J, Clasen K, Nikolaou K, et al. Clinical validation of a prognostic preclinical magnetic resonance imaging biomarker for radiotherapy outcome in head-and-neck cancer. Radiother Oncol. 2025;204:110702.","journal-title":"Radiother Oncol"},{"key":"3600_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.radonc.2018.07.020","volume":"130","author":"S Leger","year":"2019","unstructured":"Leger S, Zwanenburg A, Pilz K, Zschaeck S, Zophel K, Kotzerke J, et al. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. Radiother Oncol. 2019;130:10\u20137.","journal-title":"Radiother Oncol"},{"key":"3600_CR37","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091\u20138.","journal-title":"N Engl J Med"},{"key":"3600_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-024-01444-9","volume":"24","author":"Q Ma","year":"2024","unstructured":"Ma Q, Ren J, Wang R, Yuan Y, Tao X. Predicting response to immunotherapy in oral squamous cell carcinoma via a CT-based radiomics model. BMC Med Imaging. 2024;24:266.","journal-title":"BMC Med Imaging"},{"key":"3600_CR39","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1080\/14796694.2024.2342226","volume":"20","author":"Y Sim","year":"2024","unstructured":"Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, et al. Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma. Future Oncol. 2024;20:2869\u201378.","journal-title":"Future Oncol"},{"key":"3600_CR40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1007\/s00259-021-05610-x","volume":"49","author":"JL Vos","year":"2022","unstructured":"Vos JL, Zuur CL, Smit LA, de Boer JP, Al-Mamgani A, van den Brekel MWM, et al. [(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:2010\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3600_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamaoto.2021.4052","volume":"148","author":"H Shah","year":"2022","unstructured":"Shah H, Wang Y, Cheng SC, Gunasti L, Chen YH, Lako A, et al. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography\/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers. JAMA Otolaryngol Head Neck Surg. 2022;148:268\u201376.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3600_CR42","doi-asserted-by":"publisher","first-page":"e012143","DOI":"10.1136\/jitc-2025-012143","volume":"13","author":"D Navarro-Garcia","year":"2025","unstructured":"Navarro-Garcia D, Grussu F, Zatse C, Klumper N, Macarro C, Hernando-Calvo A, et al. Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response. J Immunother Cancer. 2025;13:e012143.","journal-title":"J Immunother Cancer"},{"key":"3600_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025;393:37\u201350.","journal-title":"N Engl J Med"},{"key":"3600_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109684","volume":"184","author":"Z Pan","year":"2023","unstructured":"Pan Z, Men K, Liang B, Song Z, Wu R, Dai J. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma. Radiother Oncol. 2023;184:109684.","journal-title":"Radiother Oncol"},{"key":"3600_CR45","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s11547-025-02072-1","volume":"130","author":"A Beddok","year":"2025","unstructured":"Beddok A, Grogg K, Nioche C, Rozenblum L, Orlhac F, Calugaru V, et al. Predicting tumor recurrence site after reirradiation in head and neck cancer: a retrospective external validation of a published [18F]-FDG PET radiomic signature. Radiol Med. 2025;130:1854\u201363.","journal-title":"Radiol Med"},{"key":"3600_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111312","volume":"214","author":"C Bang","year":"2026","unstructured":"Bang C, Gautier H, Le WT, Lalonde A, Bernard G, Markel D, et al. Dynamic prediction of Radiotherapy toxicities in Head and neck cancer using clinical and imaging data. Radiother Oncol. 2026;214:111312.","journal-title":"Radiother Oncol"},{"key":"3600_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111350","volume":"216","author":"GC Ugwu","year":"2026","unstructured":"Ugwu GC, Jalali F, Liu G, Li G, Langendijk JA, Alizadeh BZ. The actual performance of ML\/AI models in predicting radiation-induced toxicity in head and neck cancer: a systematic review and meta-analysis. Radiother Oncol. 2026;216:111350.","journal-title":"Radiother Oncol"},{"key":"3600_CR48","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1007\/s00330-023-09827-2","volume":"33","author":"YC Lin","year":"2023","unstructured":"Lin YC, Lin G, Pandey S, Yeh CH, Wang JJ, Lin CY, et al. Fully automated segmentation and radiomics feature extraction of hypopharyngeal cancer on MRI using deep learning. Eur Radiol. 2023;33:6548\u201356.","journal-title":"Eur Radiol"},{"key":"3600_CR49","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1007\/s00330-024-10585-y","volume":"34","author":"Y Choi","year":"2024","unstructured":"Choi Y, Bang J, Kim SY, Seo M, Jang J. Deep learning-based multimodal segmentation of oropharyngeal squamous cell carcinoma on CT and MRI using self-configuring nnU-Net. Eur Radiol. 2024;34:5389\u2013400.","journal-title":"Eur Radiol"},{"key":"3600_CR50","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1002\/mp.17793","volume":"52","author":"B Khajetash","year":"2025","unstructured":"Khajetash B, Hajianfar G, Talebi A, Mahdavi SR, Ghavidel B, Kalati FA, et al. Impact of harmonization on predicting complications in head and neck cancer after radiotherapy using MRI radiomics and machine learning techniques. Med Phys. 2025;52:5091\u2013103.","journal-title":"Med Phys"},{"key":"3600_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2967\/jnumed.121.262464","volume":"63","author":"F Orlhac","year":"2022","unstructured":"Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, et al. A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies. J Nucl Med. 2022;63:172\u20139.","journal-title":"J Nucl Med"},{"key":"3600_CR52","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/2767-9764.CRC-22-0152","volume":"3","author":"M Kazmierski","year":"2023","unstructured":"Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang SH, et al. Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics. Cancer Res Commun. 2023;3:1140\u201351.","journal-title":"Cancer Res Commun"},{"key":"3600_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109641","volume":"183","author":"ASR Mohamed","year":"2023","unstructured":"Mohamed ASR, Abusaif A, He R, Wahid KA, Salama V, Youssef S, et al. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study. Radiother Oncol. 2023;183:109641.","journal-title":"Radiother Oncol"},{"key":"3600_CR54","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240161","volume":"7","author":"J Bae","year":"2025","unstructured":"Bae J, Mani K, Czerwonka L, Vanison C, Ryu S, Prasanna P. Spatial Radiomic Graphs for Outcome Prediction in Radiation Therapy-treated Head and Neck Squamous Cell Carcinoma Using Pretreatment CT. Radiol Imaging Cancer. 2025;7:e240161.","journal-title":"Radiol Imaging Cancer"},{"key":"3600_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110368","volume":"197","author":"B Ma","year":"2024","unstructured":"Ma B, Guo J, De Biase A, van Dijk LV, van Ooijen PMA, Langendijk JA, et al. PET\/CT based transformer model for multi-outcome prediction in oropharyngeal cancer. Radiother Oncol. 2024;197:110368.","journal-title":"Radiother Oncol"},{"key":"3600_CR56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500\u201310.","journal-title":"Nat Rev Cancer"},{"key":"3600_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65240-9","volume":"14","author":"A Fanizzi","year":"2024","unstructured":"Fanizzi A, Comes MC, Bove S, Cavalera E, de Franco P, Di Rito A, et al. Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images. Sci Rep. 2024;14:14276.","journal-title":"Sci Rep"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03600-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:53:14Z","timestamp":1788447194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03600-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":57,"alternative-id":["3600"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03600-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}